Oncology & Hematology Coding Alert

ICD-10-CM:

289.81 Blood Clotting Diagnoses Scatter Under ICD-10-CM

But you’ll have to continue the search if documentation shows hemorrhagic disorder. Added specificity is the bogeyman of ICD-10-CM preparation. But you can take the fear out of the transition by knowing which common codes will fracture into multiple options and remembering the index and tabular list will steer you to the proper code. Here’s what to expect for hypercoagulation code 289.81. ICD-9-CM Code 289.81, Primary hypercoagulable state ICD-10-CM Codes D68.51, Activated protein C resistance
Factor V Leiden mutation D68.52, Prothrombin gene mutation D68.59, Other primary thrombophilia
Antithrombin III deficiency, hypercoagulable state NOS, primary hypercoagulable state NEC, primary thrombophilia NEC, protein C deficiency, protein S deficiency, thrombophilia NOS D68.61, Antiphospholipid syndrome Anticardiolipin syndrome, antiphospholipid antibody syndrome D68.62, Lupus anticoagulant syndrome Lupus anticoagulant, presence of systemic lupus erythematosus [SLE] inhibitor Diagnosis: Patients with a hypercoagulable state are at increased risk for blood clots. Remember that "hyper-" means [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All